Circular Genomics, a San Diego-based biotechnology company focused on neurological and psychiatric precision medicine using brain-derived circular RNA (circRNA) biomarkers, announced on April 24, 2026, the appointment of Dr. Henrik Zetterberg to its Scientific Advisory Board.
Dr. Zetterberg is a world-renowned expert in neurochemistry and Alzheimer's fluid biomarkers. He is a professor at the University of Gothenburg and University College London, and his research has significantly advanced the understanding and detection of neurodegenerative diseases.
The company stated that Dr. Zetterberg's expertise will help guide the development of circRNA-based diagnostics for neurological conditions. Circular Genomics aims to leverage circRNA biomarkers to improve diagnosis and treatment monitoring for diseases like Alzheimer's.
